Autopsy report · NCT05641545

IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients

“Premature discontinuation due to üoor participant recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

SLK Kliniken Heilbronn GmbH

Sponsor type

University, hospital or other

Conditions

Advanced Renal Cell Carcinoma

Interventions

IVAC

Participants

1

Sites

1

Countries

Germany

Trials that died the same way

• Ultrasound and Endometrial Hyperplasia
  “enrollment of participants has halted prematurely; difficulty with recruitment” (72% match in meaning)
• The Effect of Ovamax on Oocyte Quality
  “The study was stopped prematurely due to low recruitment rate” (69% match in meaning)
• Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
  “prolonged recruitment phase” (69% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (68% match in meaning)
• Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
  “Study halted due to slow recruitment” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.